Preventive therapy in patients with insignificantly narrowed coronary arteries: Evaluation of physician attitude and practice

Clinical Cardiology

Volumn 27, Issue 6 SUPPL. 3, 2004, Pages 328-332

  Henkin, Yaakov ^a,d   Abuful, Akram ^a,d   Yosefi, Chaim ^b   Elis, Avishay ^c   Ilia, Reuven ^a,d   Gidron, Yori ^d  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BARZILAI MEDICAL CENTER   (Israel)

^c MEIR MEDICAL CENTER   (Israel)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Aspirin; Coronary; Insignificantly narrowed arteries; Prevention; Statins

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRATE;

ADULT; ANGIOGRAPHY; ARTERY RUPTURE; ARTICLE; CARDIOLOGY; CLINICAL MEDICINE; CLINICAL PRACTICE; DISEASE COURSE; DRUG EFFICACY; EVALUATION; FAMILY MEDICINE; FEMALE; GENERAL PRACTICE; HEART INFARCTION; HUMAN; INTERNAL MEDICINE; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MORBIDITY; PHYSICIAN ATTITUDE; PRESCRIPTION; PREVENTIVE MEDICINE; PROGNOSIS; RANDOMIZATION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 2542548062     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960270605     Document Type: Article

References (13)

1. DeMaria AN, Lee G, Amsterdam EA, Low R, Mason DT: The anginal syndrome with normal coronary arteries. Etiologic and prognostic considerations. J Am Med Assoc 1980;244:826-828
2. ACC/AHA/ACP-ASIM Guidelines for the Management of Patients with Chronic Stable Angina: Executive Summary and Recommendations. Circulation 1999;99:2829-2848
3. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am MedAssoc 2001;285:2486-2497
4. Harats D, Rubinstein A: Joint recommendations of Israel medical societies for prevention of coronary heart disease and atherosclerosis. Harefuah 2000;138:66-74
5. Wood D: Recommendations of the Second Task Force of European and other Societies on Coronary Prevention. Eur Heart J 1998;19:1434-1503
6. Fuster V, Lewis A: Conner Memorial Lecture: Mechanisms leading to myocardial infarction: Insights from studies of vascular biology. Circulation 1994;90:2126-2146
7. Papanicolaou MN, Califf RM, Hlatky MA: Prognostic implications of angiographically normal and insignificantly narrowed coronary arteries. Am J Cardiol 1986;58:1181-1187
8. Crenshaw JH, el-Zeky F, Zwaag R, Sullivan JM, Ramanathan KB, Mirvis DM: The effect of noncritical coronary artery disease on long-term survival. Am J Cardiol Med Sci 1995;310:7-13
9. Moise A, Théroux P, Taeymans Y, Waters DD: Factors associated with progression of coronary artery disease in patients with normal or minimally narrowed coronary arteries. Am J Cardiol 1985;56:30-34
10. Ambrose JA, Tannenbaum MA, Alexopoulos D, Hjemdahl-Monson CE, Leavy J, Weiss M, Borrico S, Gorlin R, Fuster V: Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988;12:56-62
11. Little WC, Constantinescu M, Applegate RJ, Kutcher MA, Burrows MT, Kahl FR, Santamore WP: Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild to moderate coronary artery disease? Circulation 1988;78:1157-1166
12. Brown BG, Zhao X-Q, Chait A, Fisher LD, Cheung MC, Morse JS, Dowdy AA, Marino EK, Bolson EL, Alaupovic P, Frohlich J, Serafini L, Huss-Frechette E, Wang S, DeAngelis DD, Dodek A, Albers JJ: Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001;345:1583-1592
13. Voelker W, Euchner U, Dittmann H, Karsch KR: Long-term clinical course of patients with angina and angiographically normal coronary arteries. Clin Cardiol 1991;4:307-311